State Of Wyoming Verve Therapeutics, Inc. Transaction History

State Of Wyoming

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$11.14 - $23.17 $7,040 - $14,643	-632 Reduced 83.93%	121 $2,000
Q1 2022 May 13, 2022	BUY	$20.92 - $39.36 $4,686 - $8,816	224 Added 42.34%	753 $17,000
Q4 2021 Feb 11, 2022	BUY	$31.94 - $54.82 $2,267 - $3,892	71 Added 15.5%	529 $20,000
Q3 2021 Feb 11, 2022	BUY	$46.0 - $73.99 $21,068 - $33,887	458 New	458 $22,000

186

73.3M

85K

215K

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $317M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.